New research suggests that individuals who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds much more quickly than those who end conventional lifestyle plans.
Research printed in a prominent health publication demonstrates that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"Users using such treatments should be informed of the potential of quick rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.
This pace of regain means a return to pre-treatment weight in about one and a half years.
Weighing Therapies
The analysis, which examined dozens of trials involving over 9,000 of patients, compared the outcomes of these new drugs with older methods.
Scientists emphasize that individuals who shed pounds through diet and exercise generally see a slower creep back—around 0.1 kg a month—after stopping.
The Reason for the Rapid Regain
Nutrition scientists believe the way of the drugs is key to understanding the accelerated regain.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of the hormone levels several times higher than normal may cause the system to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication means hunger is no longer kept in check, making overeating a significant risk."
An Ongoing Issue?
Medical guidelines advise the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, given the high risk of weight regain, the treatment might need to be life-long.
This opinion is reinforced by pharmaceutical companies, who say that the results "emphasize the persistent nature of obesity," akin to managing diseases like diabetes.
Patient Testimonies
Users who have discontinued the jabs report a powerful return of hunger.
"It felt as if a trigger flipping and you're instantly ravenous," recalled an individual.
The struggle is compounded if individuals have not developed sustainable dietary or behavioural modifications during therapy.
Growing Interest
Recent estimates suggest that a significant number of people in the UK have tried these injections in the past year, with desire continuing to grow.
- Use is higher among women than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many access the drugs through private healthcare rather than public health services.
Finally, clinicians stress that while the jabs are potent agents for shedding pounds, they are not a magic cure and maintained weight loss hinges on ongoing behavioural management.
